Congenital bleeding disorder Trials in Los Angeles, United States
Conditions / Congenital bleeding disorder / Los Angeles, United States
Research into Congenital bleeding disorder spans multiple therapeutic approaches and trial phases.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01561391 | Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery | COMPLETED | PHASE4 |
| NCT01467427 | Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B. | COMPLETED | PHASE3 |
| NCT02141074 | Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B | COMPLETED | PHASE3 |
| NCT00108758 | Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia | COMPLETED | PHASE2 |
| NCT01395810 | Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773 | COMPLETED | PHASE3 |
| NCT01386528 | Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B | COMPLETED | PHASE3 |
| NCT01333111 | Safety and Efficacy of NNC-0156-0000-0009 in Haemophilia B Patients | COMPLETED | PHASE3 |
| NCT00108797 | Trial of NovoSeven® in Haemophilia - Joint Bleeds | COMPLETED | PHASE4 |
| NCT00486278 | Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds | COMPLETED | PHASE2 |
| NCT02137850 | Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A | COMPLETED | PHASE3 |